ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/07/04 | 3,160 | 3,215 | 3,080 | 3,115 | -5 | -0.2% | 1,507,100 |
| 2025/07/03 | 3,150 | 3,255 | 3,080 | 3,120 | -15 | -0.5% | 2,124,400 |
| 2025/07/02 | 3,200 | 3,240 | 3,115 | 3,135 | -165 | -5% | 3,425,300 |
| 2025/07/01 | 3,405 | 3,445 | 3,280 | 3,300 | -135 | -3.9% | 1,521,100 |
| 2025/06/30 | 3,490 | 3,535 | 3,400 | 3,435 | -40 | -1.2% | 1,252,300 |
| 2025/06/27 | 3,420 | 3,520 | 3,345 | 3,475 | +40 | +1.2% | 1,769,700 |
| 2025/06/26 | 3,645 | 3,670 | 3,425 | 3,435 | -230 | -6.3% | 2,050,500 |
| 2025/06/25 | 3,540 | 3,720 | 3,535 | 3,665 | +135 | +3.8% | 1,906,300 |
| 2025/06/24 | 3,730 | 3,750 | 3,520 | 3,530 | -195 | -5.2% | 2,181,500 |
| 2025/06/23 | 3,720 | 3,845 | 3,695 | 3,725 | -40 | -1.1% | 1,109,900 |
| 2025/06/20 | 3,730 | 3,820 | 3,700 | 3,765 | +40 | +1.1% | 1,316,800 |
| 2025/06/19 | 3,795 | 3,830 | 3,700 | 3,725 | -55 | -1.5% | 1,122,100 |
| 2025/06/18 | 3,725 | 3,950 | 3,725 | 3,780 | ±0 | ±0% | 2,037,800 |
| 2025/06/17 | 3,820 | 3,825 | 3,720 | 3,780 | -40 | -1% | 1,115,700 |
| 2025/06/16 | 3,715 | 3,830 | 3,685 | 3,820 | +145 | +3.9% | 1,875,600 |
| 2025/06/13 | 3,735 | 3,740 | 3,560 | 3,675 | -35 | -0.9% | 2,501,000 |
| 2025/06/12 | 3,720 | 3,795 | 3,675 | 3,710 | -60 | -1.6% | 1,732,000 |
| 2025/06/11 | 3,855 | 3,865 | 3,670 | 3,770 | +125 | +3.4% | 4,332,600 |
| 2025/06/10 | 3,900 | 3,950 | 3,640 | 3,645 | -275 | -7% | 4,394,400 |
| 2025/06/09 | 4,155 | 4,170 | 3,865 | 3,920 | -180 | -4.4% | 2,390,400 |
| 2025/06/06 | 4,165 | 4,220 | 4,050 | 4,100 | -100 | -2.4% | 2,103,000 |
| 2025/06/05 | 4,160 | 4,340 | 4,110 | 4,200 | +50 | +1.2% | 2,720,600 |
| 2025/06/04 | 4,175 | 4,325 | 4,105 | 4,150 | +15 | +0.4% | 2,881,000 |
| 2025/06/03 | 3,995 | 4,165 | 3,885 | 4,135 | +75 | +1.8% | 3,425,600 |
| 2025/06/02 | 4,265 | 4,300 | 4,015 | 4,060 | -230 | -5.4% | 3,593,200 |
| 2025/05/30 | 3,995 | 4,320 | 3,980 | 4,290 | +235 | +5.8% | 4,327,600 |
| 2025/05/29 | 4,240 | 4,410 | 4,015 | 4,055 | -300 | -6.9% | 5,318,900 |
| 2025/05/28 | 4,010 | 4,365 | 3,965 | 4,355 | +250 | +6.1% | 6,563,900 |
| 2025/05/27 | 3,890 | 4,345 | 3,810 | 4,105 | +630 | +18.1% | 17,730,300 |
| 2025/05/26 | 3,475 | 3,475 | 3,475 | 3,475 | +504 | +17% | 75,000 |
| 2025/05/23 | 2,971 | 2,971 | 2,971 | 2,971 | +500 | +20.2% | 185,700 |
| 2025/05/22 | 2,430 | 2,481 | 2,397 | 2,471 | -9 | -0.4% | 1,003,000 |
| 2025/05/21 | 2,614 | 2,617 | 2,479 | 2,480 | -109 | -4.2% | 1,411,500 |
| 2025/05/20 | 2,592 | 2,624 | 2,513 | 2,589 | +3 | +0.1% | 1,450,900 |
| 2025/05/19 | 2,690 | 2,713 | 2,541 | 2,586 | -120 | -4.4% | 2,204,300 |
| 2025/05/16 | 2,585 | 2,711 | 2,568 | 2,706 | +310 | +12.9% | 3,703,500 |
| 2025/05/15 | 2,392 | 2,440 | 2,376 | 2,396 | -80 | -3.2% | 1,125,300 |
| 2025/05/14 | 2,488 | 2,504 | 2,451 | 2,476 | -10 | -0.4% | 1,027,300 |
| 2025/05/13 | 2,431 | 2,490 | 2,431 | 2,486 | +112 | +4.7% | 1,524,000 |
| 2025/05/12 | 2,411 | 2,460 | 2,351 | 2,374 | +13 | +0.6% | 1,209,000 |
| 2025/05/09 | 2,330 | 2,396 | 2,330 | 2,361 | +45 | +1.9% | 876,300 |
| 2025/05/08 | 2,300 | 2,345 | 2,283 | 2,316 | -2 | -0.1% | 795,300 |
| 2025/05/07 | 2,385 | 2,395 | 2,308 | 2,318 | -97 | -4% | 1,244,000 |
| 2025/05/02 | 2,374 | 2,433 | 2,353 | 2,415 | +25 | +1% | 1,233,300 |
| 2025/05/01 | 2,350 | 2,434 | 2,332 | 2,390 | +32 | +1.4% | 1,363,400 |
| 2025/04/30 | 2,320 | 2,387 | 2,303 | 2,358 | +76 | +3.3% | 1,954,200 |
| 2025/04/28 | 2,298 | 2,338 | 2,263 | 2,282 | -3 | -0.1% | 1,127,100 |
| 2025/04/25 | 2,258 | 2,329 | 2,224 | 2,285 | +48 | +2.1% | 1,528,500 |
| 2025/04/24 | 2,330 | 2,351 | 2,222 | 2,237 | +37 | +1.7% | 1,828,000 |
| 2025/04/23 | 2,225 | 2,248 | 2,174 | 2,200 | +10 | +0.5% | 1,752,500 |
51～
100
件表示中 / 3785件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 249,900円 | +21.7% | +999.9% | 0.00% | 11.51倍 | 3.94倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 385,000円 | -6.4% | -71.8% | 4.94% | 42.88倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 292,000円 | +7.9% | -3.3% | 2.74% | 8.12倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 持田薬 | 320,500円 | +5.1% | -7.0% | 2.50% | 21.04倍 | 0.87倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 209,900円 | +3.1% | -6.5% | 2.29% | 9.74倍 | 1.03倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
